Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
This will be an added advantage for Supriya Lifescience Limited in the European market.
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
The drug is expected to cater to the fast growing Rheumatoid Arthritis, Plaque Psoriasis, JIA, Psoriatic Arthritis, Ankylosing Spondylitis, Ulcerative Colitis, Crohns disease, HS and Uveitis markets
Subscribe To Our Newsletter & Stay Updated
